Physician profile
Gavin Ho
NPI 1760942841
$1,657.26
in general payments reported to CMS, 2019-2025
12 companies · $1,630 in 2025
The $1,630 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $27.42 · 2025: $1,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $421.41 | 2025 | Airsupra, Lokelma, Farxiga |
| Glaxosmithkline, LLC. | $309.37 | 2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $296.13 | 2025 | Wegovy, Ozempic |
| Pfizer INC. | $185.77 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $151.36 | 2025 | Eliquis |
| Amgen INC. | $80.12 | 2024-2025 | Tavneos |
| Sanofi Pasteur INC. | $62.67 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.32 | 2025 | |
| Lilly USA, LLC | $30.48 | 2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $30.21 | 2025 | Capvaxive, Gardasil 9, M-M-R II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.13 | 2025 | Jardiance |
| Exact Sciences Corporation | $20.29 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.